Cardiac metaiodobenzylguanidine activity can predict the long-term efficacy of angiotensin-converting enzyme inhibitors and/or beta-adrenoceptor blockers in patients with heart failure
作者： Tomoaki Nakata , Takeru Wakabayashi , Michifumi Kyuma , Toru Takahashi , Kazufumi Tsuchihashi
DOI: 10.1007/S00259-004-1624-8
关键词:
摘要: Purpose Although the benefits of treatment with angiotensin-converting enzyme (ACE) inhibitors and beta-blockers are well known, no method has as yet been established to predict efficacy drug therapy. This study tested whether cardiac 123I-metaiodobenzylguanidine (MIBG) activity is prognostic value can improvement in heart failure patients resulting from ACE and/or beta-blockers.
springer.com
sci-hub.se 参考文章(27)
Sharon Ann Hunt, None, ACC/AHA 2005 guideline update for the diagnosis and management of chronic heart failure in the adult: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure). Journal of the American College of Cardiology. ,vol. 46, pp. 1116- 1143 ,(2005) , 10.1016/J.JACC.2005.08.022
Michael C. Tobes, Donald M. Wieland, James C. Sisson, Sandford Jaques, Effect of Uptake-one inhibitors on the uptake of norepinephrine and metaiodobenzylguanidine The Journal of Nuclear Medicine. ,vol. 26, pp. 897- 907 ,(1985)
Alain Cohen-Solal, Yves Esanu, Damien Logeart, Fabienne Pessione, Claude Dubois, Gilles Dreyfus, René Gourgon, Pascal Merlet, Cardiac metaiodobenzylguanidine uptake in patients with moderate chronic heart failure: relationship with peak oxygen uptake and prognosis Journal of the American College of Cardiology. ,vol. 33, pp. 759- 766 ,(1999) , 10.1016/S0735-1097(98)00608-1
H.V. Barron, M.D. Lesh, Autonomic nervous system and sudden cardiac death. Journal of the American College of Cardiology. ,vol. 27, pp. 1053- 1060 ,(1996) , 10.1016/0735-1097(95)00615-X
Graeme Eisenhofer, Peter Friberg, Bengt Rundqvist, Arshed A. Quyyumi, Gavin Lambert, David M. Kaye, Irwin J. Kopin, David S. Goldstein, Murray D. Esler, Cardiac Sympathetic Nerve Function in Congestive Heart Failure Circulation. ,vol. 93, pp. 1667- 1676 ,(1996) , 10.1161/01.CIR.93.9.1667
A.Iain McGhie, James R. Corbett, Marvin S. Akers, Padmakur Kulkarni, Michael N. Sills, Mark Kremers, L.Maximilian Buja, Marc Durant-Reville, Robert W. Parkey, James T. Willerson, Regional cardiac adrenergic function using I-123 meta-iodobenzylguanidine tomographic imaging after acute myocardial infarction. American Journal of Cardiology. ,vol. 67, pp. 236- 242 ,(1991) , 10.1016/0002-9149(91)90552-V
Tomoaki Nakata, Kazuhiko Nagao, Kazufumi Tsuchihashi, Akiyosi Hashimoto, Shigemichi Tanaka, Osamu Iimura, Regional Cardiac Sympathetic Nerve Dysfunction and the Diagnostic Efficacy of Metaiodobenzylguanidine Tomography in Stable Coronary Artery Disease The American Journal of Cardiology. ,vol. 78, pp. 292- 297 ,(1996) , 10.1016/S0002-9149(96)00280-9
Douglas P. Zipes, Sympathetic Stimulation and Arrhythmias New England Journal of Medicine. ,vol. 325, pp. 656- 657 ,(1991) , 10.1056/NEJM199108293250911
H Inoue, D P Zipes, Results of sympathetic denervation in the canine heart: supersensitivity that may be arrhythmogenic. Circulation. ,vol. 75, pp. 877- 887 ,(1987) , 10.1161/01.CIR.75.4.877
Jay N. Cohn, Gianni Tognoni, A randomized trial of the angiotensin-receptor blocker valsartan in chronic heart failure. The New England Journal of Medicine. ,vol. 345, pp. 1667- 1675 ,(2001) , 10.1056/NEJMOA010713